Cosmos Health Yönetim

Yönetim kriter kontrolleri 2/4

Cosmos Health CEO'su Greg Siokas, Feb2016 tarihinde atandı, in görev süresi 8.75 yıldır. in toplam yıllık tazminatı $ 2.80M olup, şirket hissesi ve opsiyonları dahil olmak üzere 35.7% maaş ve 64.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 13.35% ine doğrudan sahiptir ve bu hisseler $ 2.16M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.4 yıl ve 4.3 yıldır.

Anahtar bilgiler

Greg Siokas

İcra Kurulu Başkanı

US$2.8m

Toplam tazminat

CEO maaş yüzdesi	35.7%
CEO görev süresi	8.8yrs
CEO sahipliği	13.3%
Yönetim ortalama görev süresi	6.4yrs
Yönetim Kurulu ortalama görev süresi	4.3yrs

Son yönetim güncellemeleri

Recent updates

Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Aug 16

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

Feb 23

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Jul 20

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Jul 06

CEO Tazminat Analizi

Greg Siokas'un ücretlendirmesi Cosmos Health'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$34m
Jun 30 2024	n/a	n/a	-US$29m
Mar 31 2024	n/a	n/a	-US$27m
Dec 31 2023	US$3m	US$1m	-US$26m
Sep 30 2023	n/a	n/a	-US$43m
Jun 30 2023	n/a	n/a	-US$42m
Mar 31 2023	n/a	n/a	-US$59m
Dec 31 2022	US$600k	n/a	-US$64m
Sep 30 2022	n/a	n/a	-US$35m
Jun 30 2022	n/a	n/a	-US$35m
Mar 31 2022	n/a	n/a	-US$19m
Dec 31 2021	n/a	n/a	-US$16m
Sep 30 2021	n/a	n/a	-US$7m
Jun 30 2021	n/a	n/a	-US$5m
Mar 31 2021	n/a	n/a	-US$870k
Dec 31 2020	n/a	n/a	US$821k
Sep 30 2020	n/a	n/a	US$2m
Jun 30 2020	n/a	n/a	-US$648k
Mar 31 2020	n/a	n/a	-US$4m
Dec 31 2019	n/a	n/a	-US$3m
Sep 30 2019	n/a	n/a	-US$13m
Jun 30 2019	n/a	n/a	-US$9m
Mar 31 2019	n/a	n/a	-US$6m
Dec 31 2018	n/a	n/a	-US$9m
Sep 30 2018	n/a	n/a	-US$2m
Jun 30 2018	n/a	n/a	-US$6m
Mar 31 2018	n/a	n/a	-US$7m
Dec 31 2017	US$250k	n/a	-US$6m

Tazminat ve Piyasa: Greg 'nin toplam tazminatı ($USD 2.80M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 647.72K ).

Tazminat ve Kazançlar: Greg şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Greg Siokas (59 yo)

8.8yrs

Görev süresi

US$2,800,000

Tazminat

Mr. Grigorios Siokas, also known as Greg, has been the Chairman and Chief Executive Officer of Cosmos Health Inc. (formerly known as Cosmos Holdings Inc.) since February 26, 2016 and served as its Presiden...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Grigorios Siokas	Chairman & CEO	8.8yrs	US$2.80m	13.35% $ 2.2m
Georgios Terzis	Chief Financial Officer	4yrs	US$435.48k	3.05% $ 494.8k
Nikolaos Bardakis	Chief Operating Officer	1.8yrs	US$49.58k	0.21% $ 34.7k
Demetrios Demetriades	Secretary & Independent Director	10.8yrs	US$32.65k	0.095% $ 15.4k

6.4yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: COSM 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Grigorios Siokas	Chairman & CEO	8.8yrs	US$2.80m	13.35% $ 2.2m
Demetrios Demetriades	Secretary & Independent Director	10.8yrs	US$32.65k	0.095% $ 15.4k
Manfred Ziegler	Independent Director	1.9yrs	US$30.15k	0.095% $ 15.4k
Peter Goldstein	Member of Advisory Board	no data	Veri yok	Veri yok
Anastasios Tzikas	Member of Advisory Board	6yrs	Veri yok	Veri yok
Anastasios Aslidis	Independent Director	2.6yrs	US$130.60k	0.19% $ 30.9k
John Hoidas	Independent Director	8yrs	US$32.65k	0.095% $ 15.4k
Panagiotis Zoumboulakis	Member of Advisory Board	2.3yrs	Veri yok	Veri yok
Suhel Bhutawala	Independent Director	1.2yrs	US$83.40k	0.14% $ 23.1k
Vassos Efthymiadis	Member of Advisory Board	no data	Veri yok	Veri yok
Ioannis Dedes	Member of Advisory Board	no data	Veri yok	Veri yok

4.3yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: COSM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).

Cosmos Health Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Cosmos Health Inc., Annual General Meeting, Nov 19, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Cosmos Health Inc. Announces Executive and Board Changes

Cosmos Health Inc., Annual General Meeting, Sep 18, 2023

Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer

Recent updates

New major risk - Shareholder dilution

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Cosmos Health Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price

Cosmos Health Inc., Annual General Meeting, Nov 19, 2024

Cosmos Health Inc. Provides Earnings Guidance for the Year 2024, 2025, 2026, 2027

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Cosmos Health Inc. announced delayed 10-Q filing

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of its Forms 10-K and 10-Q

Cosmos Health Inc. announced delayed 10-Q filing

Cosmos Health Inc. announced delayed annual 10-K filing

Cosmos Health Inc. Receives Non-Compliance Letter from Nasdaq Related to Minimum Bid Price

Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform

Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market

New major risk - Financial position

Cosmos Health Inc. has filed a Follow-on Equity Offering in the amount of $5.049535 million.

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) completed the acquisition of Cloudscreen.

Cosmos Health Inc. announced delayed 10-Q filing

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) signed an agreement to acquire Cloudscreen.

Cosmos Health Inc. Announces Executive and Board Changes

Cosmos Health Inc. Provides Earnings Guidance for the Year 2023

Cosmos Health Inc., Annual General Meeting, Sep 18, 2023

Cosmos Health Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: US$0.091 loss per share (vs US$23.37 loss in 2Q 2022)

Cosmos Health Inc. announced that it has received $5.25 million in funding

Cosmos Holdings Inc. (NasdaqCM:COSM) acquired 100% stakes in Cana Laboratories S.A. for approximately $1.67 million.

Cosmos Health Inc. Launches Terra Creta

Cosmos Health Inc. entered into letter of intent agreement to acquire Docpharm Arzneimittelvertrieb Gmbh & Co. Kg Auf Aktien.

Cosmos Health Inc. announced delayed 10-Q filing

Full year 2022 earnings released: US$33.16 loss per share (vs US$23.74 loss in FY 2021)

Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer

Cosmos Health Inc. (NasdaqCM:COSM) announces an Equity Buyback for $3 million worth of its shares.

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Chairman & CEO exercised options to buy US$605k worth of stock.

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Third quarter 2022 earnings released: US$0.077 loss per share (vs US$0.11 loss in 3Q 2021)

Cosmos Holdings Inc., Annual General Meeting, Dec 02, 2022

Cosmos Holdings Inc. has completed a Follow-on Equity Offering in the amount of $7.5 million.

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a non-binding letter of intent agreement to acquire ZipDoctor, Inc from American International Holdings Corp. (OTCPK:AMIH).

Cosmos Holdings intends to acquire telemedicine platform ZipDoctor

Cosmos Holdings reports Q2 results

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price

Cosmos changes name to Cosmos Healthto

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a binding letter of intent to acquire Cana Laboratories S.A.

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Cosmos Holdings, Inc. Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into an agreement to acquire product portfolio of Life NLB, Ltd.

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings, Inc. Launches Osteodome in EU

Cosmos Holdings Inc. Launches New Proprietary Enhanced Dietary Supplement

Cosmos Holdings Inc. Appoints Georgios Terzis as Chief Financial Officer

Cosmos Holdings Inc. Announces David Lowenstein Agrees to Join Cosmos Board of Directors

Cosmos Holdings Inc. Announces Executive Changes

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi